We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AusPAR: Ultomiris
Australian Public Assessment Report
Device/Product Name
Ultomiris
Active ingredients
Ravulizumab
AusPAR Date
Published
Submission Number
PM-2023-02695-1-1
Submission Type
Extension of indication
Decision
Approved